Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole.
Open Access
- 1 February 1986
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 21 (2) , 227-230
- https://doi.org/10.1111/j.1365-2125.1986.tb05180.x
Abstract
Increasing doses of adenosine were given by rapid intravenous bolus to seven patients with spontaneous supraventricular tachycardia. Adenosine restored sinus rhythm in 10 of 14 episodes of narrow complex tachycardia. In those patients in whom adenosine produced only transient ventricular slowing the underlying rhythm was atrial flutter. Transient dyspnoea occurred in all patients. In two patients taking dipyridamole the mean dose of adenosine which produced an electrophysiologic effect (restoration of sinus rhythm or ventricular slowing to under 100 beats min-1) was 1.0 +/- 0.52 mg, whereas in other patients the mean dose was 8.8 +/- 2.6 mg, suggesting potentiation of the action of adenosine by dipyridamole.This publication has 8 references indexed in Scilit:
- Adenosine stimulates respiration in man.British Journal of Clinical Pharmacology, 1985
- Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardiaEuropean Heart Journal, 1984
- Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.Circulation, 1983
- Dipyridamole inhibition of adenosine metabolism in human bloodEuropean Journal of Pharmacology, 1983
- Subclasses of external adenosine receptors.Proceedings of the National Academy of Sciences, 1980
- The effect of adenosine on cardiac irregularities in manAmerican Heart Journal, 1933
- The Action of Adenosine Upon the Human HeartQJM: An International Journal of Medicine, 1930
- The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart1The Journal of Physiology, 1929